# Polyglycolic Acid Aerostatic Patch for Air Leak Management: Results from a Decade of Pulmonary Resections Using Propensity-Score Weighting

**Authors:** Olivier Georges, Damien Basille, Julien Epailly, Florence de Dominicis, Paul-Emmanuel Esmard, Malek Ben Rahal, Alejandro Witte Pfister, Patrick Bagan, Pascal Berna, Osama Abou-Arab, Christophe Beyls

PMC · DOI: 10.1093/icvts/ivaf312 · Interdisciplinary Cardiovascular and Thoracic Surgery · 2025-12-27

## TL;DR

This study shows that using the Neoveil patch during lung surgery reduces air leaks and hospital stays, but does not significantly affect pneumonia rates.

## Contribution

The study demonstrates the effectiveness of the Neoveil patch in reducing air leak duration and hospital stay after lung resections.

## Key findings

- Neoveil use was associated with a 0.67-day reduction in air leak duration after adjustment.
- Hospital stay was reduced by 1.09 days after adjustment in patients using Neoveil.
- No significant impact on postoperative pneumonia was observed with Neoveil use.

## Abstract

Prolonged air leaks are common after thoracic surgery and may be managed with synthetic aerostatic devices. This study assessed the impact of the Neoveil patch on air leak duration, hospital stay, and postoperative pneumonia.

We conducted a retrospective monocentric study at Amiens University Hospital including adults undergoing lung resection between 2014 and 2024. Patients were divided into three groups: those receiving Neoveil, those not receiving it because of absence of indication, and those operated before its introduction in 2017. For analysis, the two latter groups were pooled as the Non-Neoveil arm. To address confounding, a propensity score was built from baseline covariates with standardized mean difference >5%, and inverse probability weighting was applied. The primary end-point was air leak duration, assessed with weighted linear regression. Secondary outcomes were hospital stay and postoperative pneumonia, analyzed with weighted linear and logistic regression.

Among 1216 patients, 313 (26%) received Neoveil. Compared with the control group, Neoveil use was associated with shorter air leak duration both before adjustment (−1.01 days; P = .0004) and after adjustment (−0.67 days; P = .0042). Hospital stay was also reduced (−1.88 days before adjustment; −1.09 days after adjustment; P = .0022). No significant difference was observed for postoperative pneumonia after adjustment (adjusted Odds Ratio 0.73, 95% Confidence Interval 0.48-1.11; P = .14).

Neoveil use was associated with reduced air leak duration and shorter hospital stay following lung resection, without significant impact on pneumonia. These findings support its potential role in enhancing postoperative recovery and highlight the need for confirmation in prospective multicentre studies.

Regardless of the surgical approach, manipulation and dissection of the lung parenchyma in thoracic surgery lead to pleural breaches, resulting in air leaks.

## Full-text entities

- **Diseases:** air leak (MESH:D004618), pneumonia (MESH:D011014)
- **Chemicals:** Polyglycolic acid (MESH:D011100), Neoveil (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12823547/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12823547/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12823547/full.md

---
Source: https://tomesphere.com/paper/PMC12823547